BelHealth Investment Partners, a New York-based healthcare-focused private equity firm, has promoted three members of its investment team with the promotions of Paul Barrett to Managing Director; Rebecca Yu to Vice President; and Peter Gurny to Senior Associate.
“Paul, Rebecca and Peter have each become integral members of our team. As our firm matures, we are pleased to recognize the accomplishments of these three key investment team members. We are confident they will continue to thrive with the increased responsibility,” said Harold Blue, Founder and Managing Partner of BelHealth. “These promotions are very well deserved and we look forward to their contributions to the firm in the coming years.”
Mr. Barrett joined BelHealth in 2013 and is active with many of the firm’s portfolio companies. He currently serves as a board member for Edmond, OK-based American Health Staffing Group which was acquired in October 2016, and he also oversees the firm’s investment in Precision Toxicology, a toxicology laboratory that was acquired in April 2014. In addition, Mr. Barrett leads the firm’s business development and origination efforts. Prior to joining BelHealth, Mr. Barrett served as an associate and analyst in CIT’s healthcare investment banking division.
Ms. Yu joined BelHealth in 2017 and is active with American Health Staffing Group and Geritrex, a maker of over-the-counter pharmaceutical products that was acquired in July 2015. She also plays an integral role in the initial review of potential platform and add-on investment opportunities. Before joining BelHealth, Ms. Yu worked as a vice president in the healthcare and consumer groups at Warburg Pincus, where she focused on sourcing, analyzing and executing growth equity and buyout opportunities in the upper middle market. Earlier in her career, she was with Goldman Sachs as a securities analyst.
Mr. Gurny joined BelHealth in 2016 and supports two of the firm’s portfolio companies, Integrated Care Physicians, a provider of emergency room management services that was acquired in August 2017, and Quick Care, a provider of pain management pharmacy services that was acquired in July 2013. Prior to joining BelHealth, Mr. Gurny worked as an associate in the leveraged finance division of Citizens Financial Group.
BelHealth invests from $20 million to $50 million in companies in three healthcare segments: services, products, and distribution. The firm is currently investing out of its second fund which closed in June 2015 at the hard cap of $350 million. Fund I was raised in 2012 with $150 million of committed capital. BelHealth is headquartered in New York (www.belhealth.com).
© 2018 Private Equity Professional | March 26, 2018